Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03853486 · ClinicalTrials.gov registry record
ATHN 9: Severe VWD Natural History Study
A clinical trial of Von Willebrand Diseases, sponsored by American Thrombosis and Hemostasis Network.
- Active
- Registry status
- 108
- Enrollment target
- 20
- Study locations
NCT03853486 is a study of Von Willebrand Diseases that is active but no longer recruiting, run by American Thrombosis and Hemostasis Network. The registered enrollment target is 108 participants, below the 716-participant average among 5 other Von Willebrand Diseases trials with a reported enrollment target (85% lower). The trial reports 20 study locations across 16 states.
The verdict
NCT03853486, a study of Von Willebrand Diseases, is active but no longer recruiting, sponsored by American Thrombosis and Hemostasis Network.
- ACTIVE NOT RECRUITING
- Registry status
- 108 participants
- Enrollment target
- 20
- Study locations
Study Summary
ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participants with clinically severe congenital VWD.
Conditions Studied
Study Locations (20)
Michigan
- University of Michigan Hemophilia and Coagulation Disorders - Ann Arbor
- Children's Hospital of Michigan Hemostasis and Thrombosis Center - Detroit
- Michigan State University Center for Bleeding and Clotting Disorders - East Lansing
Pennsylvania
- Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania - Philadelphia
- Hemophilia Center of Western Pennsylvania - Pittsburgh
Tennessee
- University of Tennessee, University Clinical Health (Memphis) - Memphis
- Vanderbilt University Medical Center - Nashville
California
- Center for Inherited Blood Disorders - Orange
Colorado
- University of Colorado Denver Hemophilia and Thrombosis Center - Aurora
Connecticut
- Connecticut Bleeding and Clotting Disorders Center - Farmington
Florida
- University of Florida Hemophilia Treatment Center - Gainesville
Georgia
- Children's Healthcare of Atlanta/Emory - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2026-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03853486
The ClinicalTrials.gov registry entry for NCT03853486 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 716-participant average among 5 other Von Willebrand Diseases trials with a reported enrollment target (85% lower). The listed sponsor is American Thrombosis and Hemostasis Network, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Von Willebrand Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT03853486 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Michigan, Pennsylvania, Tennessee.
Frequently Asked Questions
What is clinical trial NCT03853486 about?
NCT03853486 is a clinical study titled "ATHN 9: Severe VWD Natural History Study". ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participants with clinically severe congenital VWD.
What is the current status of trial NCT03853486?
This trial is currently active not recruiting. The enrollment target is 108 participants. The study started on 2019-06-18. Estimated completion is 2026-07-30.
What conditions does trial NCT03853486 study?
This clinical trial studies the following conditions: Von Willebrand Diseases.
Who is sponsoring clinical trial NCT03853486?
This trial is sponsored by American Thrombosis and Hemostasis Network, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03853486 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Von Willebrand Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
RECRUITING
-
Von Willebrand Factor in Pregnancy (VIP) Study
RECRUITING
-
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
RECRUITING · Phase 1
-
Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.